Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: A role for endogenous fatty-acid ethanolamides?
Open Access
- 8 September 2006
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 550 (1-3) , 68-77
- https://doi.org/10.1016/j.ejphar.2006.08.045
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2Journal of Lipid Research, 2005
- A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neuronsNeuropharmacology, 2005
- Prevention by celecoxib of secondary hyperalgesia induced by formalin in ratsLife Sciences, 2004
- Selective inhibitors of cyclo‐oxygenase‐2 (COX‐2) induce hypoalgesia in a rat paw model of inflammationBritish Journal of Pharmacology, 2002
- Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathyProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- CB2 cannabinoid receptor-mediated peripheral antinociceptionPublished by Wolters Kluwer Health ,2001
- Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compoundsBritish Journal of Pharmacology, 2000
- EFFICIENT DESIGNS FOR STUDYING SYNERGISTIC DRUG COMBINATIONSLife Sciences, 1997
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990